Journal of the American College of Cardiology
Transthyretin Cardiac Amyloidosis Evaluation and Management: 2025 ACC Concise Clinical Guidance.
Writing Committee, Michelle M Kittleson, Amrut V Ambardekar, Richard K Cheng, Jan M Griffin, Mathew S Maurer, Jose Nativi-Nicolau, Frederick L Ruberg
Published: 202510.1016/j.jacc.2025.09.004
Abstract
Transthyretin amyloid cardiomyopathy has emerged as an increasingly recognized cause of heart failure, particularly in older individuals. There is now greater awareness of transthyretin amyloid cardiomyopathy as an underlying etiology of heart failur…
Preview only. Read the full abstract at the source